Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0XOZXZ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
SIB-029A
|
|||||
| Synonyms |
SIB-029A; SIB 029A
Click to Show/Hide
|
|||||
| Organization |
Systimmune, Inc.; Sichuan Baili Pharmaceutical Co., Ltd.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 3 Indication(s)
Colon cancer [ICD11:2B90]
Clinical candidate
Head and neck cancer [ICD11:2B60-2B6E]
Clinical candidate
Lung cancer [ICD11:2C25]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Epidermal growth factor receptor (EGFR); Receptor tyrosine-protein kinase erbB-3 (ERBB3)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.